Financial statements Lexfarma
Balance sheet of Lexfarma
Company age:
Age:
12 y. 5 m. 1 d.
Share capital:
Share capital:
10 000 PLN
Balance sheet data of LEXFARMA
|
Year
|
2022
|
2023
|
2024
|
|---|---|---|---|
| Total assets | 407 954,41 | 424 824,27 | 689 878,87 |
| A. Fixed assets | 25 388,56 | 25 132,12 | 221 021,19 |
| B. Current assets | 382 565,85 | 399 692,15 | 468 857,68 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 407 954,41 | 424 824,27 | 689 878,87 |
| A. Equity | 214 820,01 | 217 346,23 | 229 461,10 |
| B. Liabilities and provisions for liabilities | 193 134,40 | 207 478,04 | 460 417,77 |
| I. Long-term liabilities | 0,00 | 0,00 | 164 000,00 |
| II. Short-term liabilities | 193 134,40 | 207 478,04 | 296 417,77 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.